Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.

Soares AB, Altemani A, de Araújo VC.

J Oral Pathol Med. 2011 Apr;40(4):352-8. doi: 10.1111/j.1600-0714.2010.00956.x. Epub 2010 Oct 24.

PMID:
20969626
[PubMed - indexed for MEDLINE]
2.

Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma.

Soares AB, de Araújo VC, Juliano PB, Altemani A.

J Oral Pathol Med. 2009 Sep;38(8):623-9. doi: 10.1111/j.1600-0714.2009.00794.x. Epub 2009 Jun 25.

PMID:
19563505
[PubMed - indexed for MEDLINE]
3.
4.

Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma.

Soares AB, Demasi AP, Altemani A, de Araújo VC.

Histopathology. 2011 Feb;58(3):377-82. doi: 10.1111/j.1365-2559.2011.03758.x. Epub 2011 Feb 16.

PMID:
21323961
[PubMed - indexed for MEDLINE]
5.

Immunohistochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas.

DeRoche TC, Hoschar AP, Hunt JL.

Arch Pathol Lab Med. 2008 Dec;132(12):1907-11. doi: 10.1043/1543-2165-132.12.1907.

PMID:
19061288
[PubMed - indexed for MEDLINE]
6.

S100P expression in ductal type of carcinoma ex pleomorphic adenoma.

Hashimoto K, Yamamoto H, Shiratsuchi H, Nakashima T, Tamiya S, Higaki Y, Komune S, Tsuneyoshi M, Oda Y.

Am J Surg Pathol. 2011 Mar;35(3):346-55. doi: 10.1097/PAS.0b013e31820832a6.

PMID:
21317706
[PubMed - indexed for MEDLINE]
7.

Elevated expression of cyclooxygenase-2 in adenocarcinoma of the parotid gland: insights into malignant transformation of pleomorphic adenoma.

Sakamoto T, Kondo K, Yamasoba T, Sugasawa M, Kaga K.

Ann Otol Rhinol Laryngol. 2004 Nov;113(11):930-5.

PMID:
15562904
[PubMed - indexed for MEDLINE]
8.

Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study.

Stennert E, Wittekindt C, Klussmann JP, Arnold G, Guntinas-Lichius O.

Laryngoscope. 2004 Jan;114(1):158-63.

PMID:
14710014
[PubMed - indexed for MEDLINE]
9.

[Recurring tumors of the parotid gland with special reference to pleomorphic adenoma].

Ott PM, Grob U.

Schweiz Med Wochenschr. 1982 May 22;112(21):757-60. German.

PMID:
6285455
[PubMed - indexed for MEDLINE]
10.

[Recurrent benign tumors of the parotid gland and their tendency for becoming malignant].

Mann W, Beck C, Karatay MC.

Laryngol Rhinol Otol (Stuttg). 1985 Mar;64(3):133-5. German.

PMID:
2985894
[PubMed - indexed for MEDLINE]
11.

Expression profiles of p53, p63, and p73 in benign salivary gland tumors.

Weber A, Langhanki L, Schütz A, Gerstner A, Bootz F, Wittekind C, Tannapfel A.

Virchows Arch. 2002 Nov;441(5):428-36. Epub 2002 Sep 11.

PMID:
12447671
[PubMed - indexed for MEDLINE]
12.

[Recurrence tendency and malignant transformation of pleomorphic adenomas].

Chilla R, Schneider K, Droese M.

HNO. 1986 Nov;34(11):467-9. German.

PMID:
3027008
[PubMed - indexed for MEDLINE]
13.

The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.

Soares AB, Demasi AP, Tincani AJ, Martins AS, Altemani A, de Araújo VC.

J Clin Pathol. 2012 Mar;65(3):272-7. doi: 10.1136/jclinpath-2011-200405. Epub 2011 Dec 15.

PMID:
22174424
[PubMed - indexed for MEDLINE]
14.

Malignant myo-epithelioma of the parotid gland arising in a pleomorphic adenoma.

Di Palma S, Pilotti S, Rilke F.

Histopathology. 1991 Sep;19(3):273-5. No abstract available.

PMID:
1655615
[PubMed - indexed for MEDLINE]
15.

Expression of CD44V6 in parotid pleomorphic adenoma and carcinoma ex pleomorphic adenoma.

Yang S, Wang HP, Wang XY, Guo LJ, Tang XF, Gao QH, Xuan M, Loo WT, Chow LW.

Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S101-8. doi: 10.1517/13543781003718866.

PMID:
20374021
[PubMed - indexed for MEDLINE]
16.

[Malignant mixed tumors of the parotid gland: a review of the Department of Otolaryngology Medical University of Warsaw experience].

Szwedowicz P, Osuch-Wójcikiewicz E, Bruzgielewicz A, Chęciński P, Nyckowska J.

Otolaryngol Pol. 2012 Sep;66(4 Suppl):4-10. doi: 10.1016/S0030-6657(12)70777-1. Polish.

PMID:
23164099
[PubMed - indexed for MEDLINE]
17.

[Ezrin and inducible nitric oxide synthase in malignant proliferation of salivary gland pleomorphic adenoma].

Wang YY, Chen WL, Zhang WX, Bai ZB, Huang ZQ, Li JS.

Ai Zheng. 2009 Oct;28(10):1072-6. Chinese.

PMID:
19799816
[PubMed - indexed for MEDLINE]
18.

Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma.

Katori H, Nozawa A, Tsukuda M.

Auris Nasus Larynx. 2007 Mar;34(1):79-84. Epub 2006 Oct 17.

PMID:
17049779
[PubMed - indexed for MEDLINE]
19.

Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.

Matsubayashi S, Yoshihara T.

Eur Arch Otorhinolaryngol. 2007 Jul;264(7):789-95. Epub 2007 Feb 20.

PMID:
17310348
[PubMed - indexed for MEDLINE]
20.

Myoepithelial carcinoma (malignant myoepithelioma) of the parotid gland arising in a pleomorphic adenoma.

McCluggage WG, Primrose WJ, Toner PG.

J Clin Pathol. 1998 Jul;51(7):552-6.

PMID:
9797738
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk